T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Cardiovascular Therapy

• Publication date

  2014-11-22

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1586/14779072.2014.986098PMID 25418759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload

  2015cited by this paper
• Accelerated and navigator‐gated look‐locker imaging for cardiac t1 estimation (ANGIE): Development and application to T1 mapping of the right ventricle

  2015cited by this paper
• Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.

  2014influential reference
• Therapeutic targets in heart failure: refocusing on the myocardial interstitium.

  2014cited by this paper
• Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.

  2014cited by this paper
• Extracellular volume fraction is associated with B-type natriuretic peptide in hypertrophic cardiomyopathy

  2014cited by this paper
• Cardiac magnetic resonance for prognostic assessment: present applications and future directions

  2014cited by this paper
• Native T1 mapping in transthyretin amyloidosis.

  2014cited by this paper
• Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping

  2014cited by this paper
• Development of Tissue Characterization Using Optical Coherence Tomography for Defining Coronary Plaque Morphology and the Vascular Responses After Coronary Stent Implantation

  2014cited by this paper
• Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues

  2014cited by this paper
• T1-mapping in the heart: accuracy and precision

  2014cited by this paper
• A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.

  2014cited by this paper
• Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents

  2014cited by this paper
• Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification

  2014cited by this paper
• Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy

  2014cited by this paper
• Strategies and opportunities for drug development in heart failure.

  2013cited by this paper
• Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus

  2013cited by this paper
• Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease

  2013cited by this paper
• Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications for Early Cardiac Remodeling

  2013cited by this paper
• Guidelines on the Management of Valvular Heart disease (Version 2012)

  2013cited by this paper
• Cardiac magnetic resonance T1 mapping of left atrial myocardium.

  2013cited by this paper
• Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping

  2013cited by this paper
• Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.

  2013cited by this paper
• T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy

  2013cited by this paper
• T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex

  2013cited by this paper
• Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches

  2013cited by this paper
• T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

  2013cited by this paper
• Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis

  2013cited by this paper
• Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

  2013cited by this paper
• Human non-contrast T1 values and correlation with histology in diffuse fibrosis

  2013cited by this paper
• Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners

  2013cited by this paper
• Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume

  2013cited by this paper
• Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

  2013cited by this paper
• Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

  2013cited by this paper
• Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

  2013influential reference
• Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

  2013cited by this paper
• Myocardial T1 mapping: modalities and clinical applications.

  2013cited by this paper
• T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.

  2013cited by this paper
• Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

  2013cited by this paper
• Mapping with CMR Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Gender

  2013cited by this paper
• Is one better than two?: T1 mapping in myocarditis.

  2013cited by this paper
• Heart-rate independent myocardial T1-mapping using combined saturation and inversion preparation pulses

  2013cited by this paper
• Abstract 18189: Focal Fibrosis and Diffuse Fibrosis Are Predictors of Positive Left Ventricular Remodeling in Patients With Non-Ischemic Cardiomyopathy

  2013cited by this paper
• Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).

  2013cited by this paper
• Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality

  2012influential reference
• Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.

  2012cited by this paper
• Guidelines on the management of valvular heart disease (version 2012).

  2012cited by this paper
• Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study.

  2012cited by this paper
• T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region

  2012cited by this paper
• Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

  2012cited by this paper
• Pre-contrast T1 mapping for detection of myocardial fibrosis in asymptomatic and symptomatic aortic stenosis

  2012cited by this paper
• Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction

  2012cited by this paper
• Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

  2012cited by this paper
• T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

  2012cited by this paper
• Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method

  2012cited by this paper
• Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

  2012cited by this paper
• Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients: A Pilot Study

  2012cited by this paper
• Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging

  2012cited by this paper
• Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials

  2012cited by this paper
• Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy

  2012cited by this paper
• Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

  2012cited by this paper
• Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping

  2011cited by this paper
• Novel imaging techniques for diffuse myocardial fibrosis.

  2011cited by this paper
• Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

  2011influential reference
• Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy

  2011cited by this paper
• On T2* Magnetic Resonance and Cardiac Iron

  2011cited by this paper
• Text-Book on Diseases of the Heart

  2010cited by this paper
• Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease

  2010cited by this paper
• Heart failure and mouse models

  2010cited by this paper
• Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans

  2010cited by this paper
• Natural History of Very Severe Aortic Stenosis

  2010cited by this paper
• Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

  2010cited by this paper
• Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper

  2009cited by this paper
• Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.

  2009cited by this paper
• Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

  2008influential reference
• Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction

  2007cited by this paper
• Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study.

  2006cited by this paper
• Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.

  2006cited by this paper
• Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.

  2005cited by this paper
• Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy

  2005cited by this paper
• Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

  2004cited by this paper
• Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart

  2004influential reference
• Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

  2001cited by this paper
• The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

  2000cited by this paper
• Equilibrium transcytolemmal water‐exchange kinetics in skeletal muscle in vivo

  1999cited by this paper
• Molecular mechanisms of myocardial remodeling.

  1999cited by this paper
• Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.

  1996cited by this paper
• Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment.

  1995cited by this paper
• Myocardial collagen concentration and nuclear magnetic resonance relaxation times in the spontaneously hypertensive rat.

  1991cited by this paper
• Cardiac interstitium in health and disease: the fibrillar collagen network.

  1989cited by this paper
• Nuclear magnetic resonance relaxometry of the normal heart: relationship between collagen content and relaxation times of the four chambers.

  1989cited by this paper
• Characterization of human pathological papillary muscles by 1H-NMR spectroscopic and histologic analysis.

  1986cited by this paper
• Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times.

  1983cited by this paper

• CMR T1 reactivity in healthy adult hearts: a systematic review and meta-analysis

  2025cites this paper
• Hypertension-mediated Organ Damage Care in India Go-Real (Guidelines tO Real World) Application: Expert Opinion.

  2025cites this paper
• Advances in the diagnosis of myocarditis in idiopathic inflammatory myopathies: an overview of diagnostic tests

  2024cites this paper
• Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis grading

  2024cites this paper
• Current Trends and Developments in Radiologic Assessment of Chronic Pancreatitis

  2024cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard

  2022cites this paper
• T1 relaxation times and MR elastography-derived stiffness: new potential imaging biomarkers for the assessment of chronic pancreatitis

  2021cites this paper
• Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Extracellular Volume in Dilated Cardiomyopathy: Interstitial Fibrosis and More?

  2018cites this paper
• Mechanistic insights of the left ventricle structure and fibrosis in the arrhythmogenic mitral valve prolapse

  2018cites this paper
• Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension*

  2017cites this paper
• Effect of contrast dose in the quantification of myocardial extra-cellular volume in adenosine stress/rest perfusion cardiac magnetic resonance examinations

  2017cites this paper
• Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)

  2017cites this paper
• T1 mapping of the ischemic myocardium: Review of potential clinical use.

  2016cites this paper
• Recent advances in the noninvasive strategies of cardiac amyloidosis

  2016cites this paper
• The influence of the analysis technique on myocardial T1 estimation using MRI

  2016cites this paper
• Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T

  2016cites this paper
• Imaging in Deciphering Histological Substrates in Hypertrophic Cardiomyopathy

  2015cites this paper